Edition:
United States

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

37.53USD
21 Sep 2017
Change (% chg)

-- (--)
Prev Close
$37.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
829,268
52-wk High
$46.80
52-wk Low
$35.15

Chart for

About

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays,... (more)

Overall

Beta: 0.93
Market Cap(Mil.): $10,526.17
Shares Outstanding(Mil.): 280.47
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 175.94 16.34
EPS (TTM): -- -- --
ROI: -- 9.47 14.66
ROE: -- 14.70 14.00

BRIEF-Hologic updates on commercial availability of Brevera Breast Biopsy System

* Hologic inc - ‍U.S. commercial availability of Brevera Breast Biopsy System with Corlumina imaging technology​ Source text for Eikon: Further company coverage:

Aug 31 2017

BRIEF-Hologic updates on FY17 profit outlook

* Hologic says ‍updated Q3 financial results press release to correct tax impact of certain exclusions in FY net income per share guidance​ - SEC filing

Aug 03 2017

BRIEF-Hologic Q3 GAAP earnings per share $0.21

* Hologic announces financial results for third quarter of fiscal 2017

Aug 02 2017

BRIEF-Hologic obtains CE mark in Europe for Panther Fusion System

* Obtained a CE mark in Europe for its new Panther Fusion System and Panther Fusion Assays for flu and respiratory testing Source text for Eikon: Further company coverage:

Jun 29 2017

BRIEF-Hologic receives expanded FDA clearance to market Cynosure's Sculpsure

* Hologic receives expanded FDA 510(k) clearance to market Cynosure's Sculpsure® for non-invasive body contouring (lipolysis) of back, inner and outer thighs Source text for Eikon: Further company coverage:

Jun 15 2017

BRIEF-Hologic Inc updates on FDA's approval of Genius 3D mammography exam

* FDA approves Hologic's Genius™ 3D mammography™ exam as the only mammogram superior for women with dense breasts* Source text for Eikon: Further company coverage:

Jun 07 2017

BRIEF-Hologic announces Q2 revenue $715.4 million

* Hologic announces financial results for second quarter of fiscal 2017

May 10 2017

Hologic faces U.S. patent lawsuit over menstrual bleeding device

April 12 Medical device maker Hologic Inc has been hit with a lawsuit alleging its product for treating heavy menstrual bleeding infringes patented technology developed by start-up Minerva Surgical Inc, court papers show.

Apr 12 2017

Hologic faces U.S. patent lawsuit over menstrual bleeding device

Medical device maker Hologic Inc has been hit with a lawsuit alleging its product for treating heavy menstrual bleeding infringes patented technology developed by start-up Minerva Surgical Inc, court papers show.

Apr 12 2017

Hologic faces U.S. patent lawsuit over menstrual bleeding device

April 12 Medical device maker Hologic Inc has been hit with a lawsuit alleging its product for treating heavy menstrual bleeding infringes patented technology developed by start-up Minerva Surgical Inc, court papers show.

Apr 12 2017

Earnings vs. Estimates